Psilocybin therapy for caregivers of advanced cancer patients
Treatments studied
Part of Cancer, Mental health clinical trials.
This trial tests whether psilocybin-assisted therapy can help caregivers of people with advanced cancer who feel anxious or depressed. It focuses on improving emotional well-being and relationships.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and live in Ontario, Canada.
- You can speak and read English.
- You are the main caregiver for someone with advanced cancer who is in a related trial or receiving psilocybin therapy at University Health Network.
- You have at least mild anxiety or depression symptoms.
- You have normal liver and kidney function, and no uncontrolled high blood pressure, heart problems, or seizure disorder.
- You are willing to stop certain medications and avoid alcohol or other drugs before psilocybin sessions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether very low doses of psilocybin (a psychedelic substance) can help reduce emotional distress in people with a life-limiting illness. If you are receiving palliative care and feeling anxious or depressed, this study might offer a way to explore a new treatment option.
This trial tests if a medicine called psilocybin, given with talk therapy, can safely help people with advanced cancer who feel very demoralized. Demoralization is a deep sense of hopelessness or loss of meaning. The goal is to see if this treatment can improve your emotional well-being.
This trial tests if a single dose of psilocybin (a psychedelic drug from certain mushrooms) given with psychological support can help reduce long-term pain in people with cancer who are already taking opioid painkillers.
This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
Hear when a new Caregiver Distress trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.